Experimental therapy uses patients' own cells to deliver chemo directly to tumors
NCT ID NCT07198659
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether a patient's own white blood cells, loaded with a chemotherapy drug, can safely treat unresectable pancreatic cancer. Only 3 people will take part. The main goal is to check for side effects, not to cure the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of the PLA Air Force Military Medical University
RECRUITINGXi’an, Shanxi, 710000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive injection takes on tough pancreatic cancer in early trial
- New trial aims to cut opioid use in pancreatic cancer with early nerve block
- Tiny particles, big hope: new combo tackles tough cancers
- Could a measles vaccine fight pancreatic cancer?
- New drug cocktail shows promise against tough pancreatic cancer
- Sound waves take on tough pancreatic cancer